ELI LILLY & Co Logo

ELI LILLY & Co

Pharma leader developing medicines for diabetes, obesity, oncology, and neuroscience.

LLY | NYSE

Overview

Corporate Details

ISIN(s):
US5324571083
LEI:
Country:
United States of America
Address:
LILLY CORPORATE CTR, 46285 INDIANAPOLIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eli Lilly and Company is a global pharmaceutical corporation engaged in the discovery, development, manufacturing, and commercialization of human healthcare products. Founded in 1876, the company has a long history of medical innovation, focusing on creating medicines for significant health challenges. Its portfolio primarily targets non-communicable diseases, with key therapeutic areas including diabetes, oncology, immunology, and neuroscience. Lilly is widely recognized for its pioneering role in diabetes care and has more recently become a prominent leader in the development of novel therapies for obesity and related metabolic conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELI LILLY & Co

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FATE THERAPEUTICS INC Logo
Develops off-the-shelf iPSC cell therapies for cancer and autoimmune diseases.
United States of America FATE
FENNEC PHARMACEUTICALS INC. Logo
Prevents chemotherapy-induced hearing loss in children with its sole product, PEDMARK®.
United States of America FENC
FibroBiologics, Inc. Logo
Clinical-stage biotech developing fibroblast cell therapies for chronic diseases.
United States of America FBLG
FIBROGEN INC Logo
Biopharma developing first-in-class therapies for cancer, anemia, and serious conditions.
United States of America FGEN
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF
Flora Growth Corp. Logo
A diversified firm in pharma distribution, plant-based wellness, and digital assets.
United States of America FLGC
Foghorn Therapeutics Inc. Logo
Pioneering medicines targeting the chromatin regulatory system to treat genetically defined cancers.
United States of America FHTX
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Fortress Biotech, Inc. Logo
Acquires, develops, and commercializes drugs for oncology, gene therapy, and rare diseases.
United States of America FBIO
FRACTYL HEALTH, INC. Logo
Developing gut-targeted endoscopic and gene therapies for obesity and type 2 diabetes.
United States of America GUTS

Talk to a Data Expert

Have a question? We'll get back to you promptly.